DR LIM CHWEE MING graduated from the Faculty of Medicine at the National University of Singapore and subsequently underwent residency in Otolaryngology in Singapore. He decided to pursue head and neck surgery as his subspeciality and was awarded the Ministry of Health Overseas Training award to undergo Head and Neck Oncologic Fellowship at the University of Pittsburgh Medical Center in the United States of America. Presently, he is a surgeon scientist funded by the National Medical Research Council, Singapore, to translate novel cellular immunotherapies in head and neck cancer. He is practising in the Department of Otolaryngology – Head and Neck Surgery at the Singapore General Hospital. On the research front, he leads a team at the translational head and neck cancer immunotherapy lab at Academia (SGH) and is Director of the Department of Clinical Translational Research. He is an Associate Professor with the Duke-NUS Medical School.
Science Technology & Innovation |
Leveraging on Technology for Tomorrow’s Cancer Treatment
Cancer is a common disease affecting mankind and remains a significant cause of death, especially in many developed countries. Besides inflicting immense pain and suffering to patients, it also poses a huge economic burden to…